Someone FIXED their acne in 4 months with GHK-Cu.

someone FIXED their acne in 4 months with GHK-Cu.
This small copper peptide strengthens the skin barrier while repairing broken structures and lowering skin inflammation.
Weak skin barrier is where most acne starts
(1/5)🧵


It allows bacteria and toxins to enter while water leaks out, leaving your skin dry and inflamed.
That inflammation cause redness and skin pigmentation, to defend itself the skin pumps oil that can clog pores and feed bacteria.
More bacteria = More inflammation.
That's where GHK can help, it restores the barrier, nukes inflammation and tells your cells to produce more elastin and collagen so it can start healing.
That's why it's so effective at treating acne and reversing skin aging.
US source:
Ghk Cu Cosmetic 5MGrealpeptides.coView product[PMID: 42619529, 3169264, 19319546, 29986520]
Niacinamide is another powerful tool for strengthening the skin barrier and lowering oxidative stress.
It can make your skin look younger and healthier.

Vitamin E and specifically the gamma tocopherol can nuke skin inflammation, protect from free radical damage and improving the function of the barrier.
All tocopherols can be effective, using a combo of all is probably the most effective.
The E is use:
E-Complete Oral Supplementskin.foodView productMake sure the one you use is not mixed with PUFA.

Salicylic acid shown to also lower inflammation in the skin, you can use a serum product that has it or dissolve an aspirin tablet to water and apply to your face.

The studies
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene DataInt J Mol Sci · 2018 · PMID 29986520
- Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosaceaCutis · 2005 · PMID 16209160
- Topical application of a novel, hydrophilic gamma-tocopherol derivative reduces photo-inflammation in mice skinJ Invest Dermatol · 2006 · PMID 16543897
- Efficacy and safety of supramolecular salicylic acid in the treatment of papulopustular rosacea: a multicentre randomized, double-blind, placebo-controlled superiority studyClin Exp Dermatol · 2025 · PMID 40701547